Kay Elizabeth Davies

机构：University of Oxford · ORCID：0000-0001-8807-8520

发表论文 505 篇 · 总被引 33716 次 · h-index 91

代表论文

Therapies for rare diseases: therapeutic modalities, progress and challenges ahead (2019 · Nature Reviews Drug Discovery · 被引 368)
Therapeutic approaches for Duchenne muscular dystrophy (2023 · Nature Reviews Drug Discovery · 被引 124)
Control of backbone chemistry and chirality boost oligonucleotide splice switching activity (2022 · Nucleic Acids Research · 被引 64)
The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy (2019 · Human Molecular Genetics · 被引 56)
Chemical Proteomics and Phenotypic Profiling Identifies the Aryl Hydrocarbon Receptor as a Molecular Target of the Utrophin Modulator Ezutromid (2019 · Angewandte Chemie International Edition · 被引 53)
Alterations of neuromuscular junctions in Duchenne muscular dystrophy (2020 · Neuroscience Letters · 被引 43)